Doctor profile · Federal record

Dr. Amritpal Anand, MD

Rheumatology Physician (CMS: Rheumatology) · Rheumatology Physician · Rheumatology Physician · Internal Medicine Physician · Internal Medicine Physician · Elgin, IL

  • NPI 1770701716
  • Accepts Medicare
  • MIPS 93.8 / 100 · 2023
  • 22 yrs in practice
  • Licensed in 3 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
1550 N Randall RD
Elgin, IL 601237876
(815) 398-9491
fax (815) 381-7498
Additional location
11143 Parkview Plaza Dr Ste 200
Fort Wayne, IN 468451728
(260) 266-8820
fax (260) 266-8829
Mailing address
Po Box 735263
Chicago, IL 606735263

Credentials & registration

NPPES · NUCC
NPI registered
April 2007 — 19 yrs on file
Profile last updated
October 2, 2025
Year of graduation
2004 — 22 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State licenses (3)
Illinois #036118936 · Indiana #01092264A · Michigan #4301084100
Medicaid (2)
IL #036118936 · MI #1770701716

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1770701716. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
76,562
Distinct HCPCS
10
Medicare allowed
$745,213
HCPCS Description Services Patients Avg allowed
J3262 Injection, tocilizumab, 1 mg 49,400 18 $6
J3111 Injection, romosozumab-aqqg, 1 mg 14,130 15 $10
J1602 Injection, golimumab, 1 mg, for intravenous use 9,250 18 $13
J0897 Injection, denosumab, 1 mg 1,560 19 $23
A9577 Injection, gadobenate dimeglumine (multihance), per ml 371 16 $2
99214 Established patient office or other outpatient visit, 30-39 minutes 323 167 $132
96375 Injection of additional new drug or substance into vein 208 33 $16
96413 Administration of chemotherapy into vein, 1 hour or less 203 45 $137
96372 Injection of drug or substance under skin or into muscle 165 34 $15
99215 Established patient office or other outpatient visit, 40-54 minutes 157 123 $183

In context: peer comparison

Among 2 peers in this city , average services per provider: 2,388. This provider delivers 32× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$659
Transactions
18
Manufacturers
11
Payer (manufacturer) Industry Txns Amount
AstraZeneca Pharmaceuticals LP 3 $193.94
Janssen Biotech, Inc. 3 $127.96
ABBVIE INC. 2 $115.31
Amgen Inc. 2 $44.00
GlaxoSmithKline, LLC. 2 $33.23
Janssen Scientific Affairs, LLC 1 $30.28
UCB, Inc. 1 $27.47
Alexion Pharmaceuticals, Inc. 1 $25.86
PFIZER INC. 1 $25.41
Novartis Pharmaceuticals Corporation 1 $18.88
Lilly USA, LLC 1 $16.27

By nature of payment

Food and Beverage
$590
Education
$69

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,132
Patients
467
Total drug cost
$44,665
Drug Type Claims Patients Total cost
Hydroxychloroquine Sulfate Generic 288 114 $17,700
Methotrexate (Methotrexate Sodium) Brand 180 80 $8,862
Gabapentin Generic 115 52 $1,461
Leflunomide Generic 109 50 $9,767
Allopurinol Generic 93 30 $1,694
Prednisone Generic 81 46 $219
Folic Acid Generic 52 19 $214
Pantoprazole Sodium Generic 40 17 $482
Famotidine Generic 38 23 $1,075
Celecoxib Generic 32 14 $1,182

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Amritpal Anand's medical specialty?
Dr. Amritpal Anand practices Rheumatology Physician in Elgin, IL.
Where does Dr. Amritpal Anand practice?
Dr. Amritpal Anand practices at 1550 N Randall RD, Elgin, IL 601237876. Office phone: 8153989491.
What is Dr. Amritpal Anand's NPI?
Dr. Amritpal Anand's National Provider Identifier (NPI) is 1770701716, issued by NPPES.
Does Dr. Amritpal Anand accept Medicare assignment?
Yes. Dr. Amritpal Anand accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Amritpal Anand commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.